BlackRock Investment Management’s Assembly Biosciences ASMB Stock Holding History

BlackRock Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$29K	Sell	201 -11	-5%	-$1.64K	﹤0.01%	3333
2016 Q3	$18K	Buy	212 +7	+3%	+$541	﹤0.01%	3387
2016 Q2	$14K	Sell	205 -4,191	-95%	-$275K	﹤0.01%	3479
2016 Q1	$265K	Buy	4,396 +69	+2%	+$4.61K	﹤0.01%	3104
2015 Q4	$390K	Buy	4,327 +9	+0.2%	+$980	﹤0.01%	3084
2015 Q3	$495K	Buy	4,318 +91	+2%	+$16K	﹤0.01%	3029
2015 Q2	$977K	Buy	+4,227	New	+$816K	﹤0.01%	2777

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Investment Management's ASMB Position: Q4 2016 in Review

BlackRock Investment Management reduced its Assembly Biosciences (ASMB) stake by 5.2% in Q4 2016, selling an estimated $1.64K and leaving 201 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

BlackRock Investment Management first reported a position in ASMB in Q2 2015 and has held it in 7 quarters since. The position peaked at $977K in Q2 2015. 36 funds tracked by Wall St. Rank hold ASMB as of Q4 2016.

BlackRock Investment Management held 201 shares of Assembly Biosciences worth $29K as of Q4 2016.
BlackRock Investment Management sold 11 Assembly Biosciences shares in Q4 2016, an estimated $1.64K.
Assembly Biosciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3333 holding.
BlackRock Investment Management first reported a position in Assembly Biosciences in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Assembly Biosciences position peaked at $977K in Q2 2015.
36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.